PMC:7291971 / 22811-22934 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T510","span":{"begin":23,"end":32},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T511","span":{"begin":98,"end":106},"obj":"SP_10"}],"text":"The selection of these compounds was based on their percentage inhibition higher than 50% against SARS-CoV nsp14 (Table 1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T60","span":{"begin":98,"end":106},"obj":"Disease"}],"attributes":[{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The selection of these compounds was based on their percentage inhibition higher than 50% against SARS-CoV nsp14 (Table 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T159","span":{"begin":0,"end":123},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The selection of these compounds was based on their percentage inhibition higher than 50% against SARS-CoV nsp14 (Table 1)."}